Dysregulation of FicD AMPylation causes diabetes by disrupting pancreatic endocrine homeostasis
Casey, A. K.; Stewart, N. M. S.; Zaidi, N.; Gray, H. F.; Fields, H. A.; Sakurai, M.; Pinzon-Arteaga, C. A.; Evers, B. M.; Wu, J.; Orth, K.
Show abstract
Bi-functional enzyme FicD regulates the endoplasmic reticulum chaperone BiP using AMPylation and deAMPylation during ER homeostasis and stress, respectively. Human FicD with an arginine-to-serine mutation disrupts FicD deAMPylation activity resulting in severe neonatal diabetes. We generated the FicDR371S mutation in mice to create a pre-clinical murine model for neonatal diabetes. We observed elevated BiP AMPylation levels across multiple tissues and signature markers for diabetes including glucose intolerance and reduced serum insulin levels. While the pancreas of FicDR371S mice appeared normal at birth, adult FicDR371S mice displayed disturbed pancreatic islet organization that progressed with age. FicDR371S mice provide a preclinical mouse model for the study of UPR associated diabetes and demonstrate the essentiality of FicD for tissue resilience.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacologic rescue of circadian β-cell failure through P2Y1 purinergic receptor identified by small-molecule screen 95%
- Coordination between ECM and cell-cell adhesion regulates the development of islet aggregation, architecture, and functional maturation 95%
- Fluorescein-based sensors to purify human α-cells for functional and transcriptomic analyses 94%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.